vs

Side-by-side financial comparison of CAPITAL CITY BANK GROUP INC (CCBG) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $63.5M, roughly 1.3× CAPITAL CITY BANK GROUP INC). CAPITAL CITY BANK GROUP INC runs the higher net margin — 21.6% vs -38.1%, a 59.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 6.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 6.0%).

Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CCBG vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.3× larger
PRCT
$83.1M
$63.5M
CCBG
Growing faster (revenue YoY)
PRCT
PRCT
+14.2% gap
PRCT
20.2%
6.0%
CCBG
Higher net margin
CCBG
CCBG
59.7% more per $
CCBG
21.6%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
6.0%
CCBG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CCBG
CCBG
PRCT
PRCT
Revenue
$63.5M
$83.1M
Net Profit
$13.7M
$-31.6M
Gross Margin
64.9%
Operating Margin
29.3%
-4.1%
Net Margin
21.6%
-38.1%
Revenue YoY
6.0%
20.2%
Net Profit YoY
4.7%
-27.9%
EPS (diluted)
$0.80
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCBG
CCBG
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$63.5M
$76.4M
Q3 25
$65.9M
$83.3M
Q2 25
$63.2M
$79.2M
Q1 25
$61.5M
$69.2M
Q4 24
$59.9M
$68.2M
Q3 24
$59.7M
$58.4M
Q2 24
$58.9M
$53.4M
Net Profit
CCBG
CCBG
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$13.7M
$-29.8M
Q3 25
$15.9M
$-21.4M
Q2 25
$15.0M
$-19.6M
Q1 25
$16.9M
$-24.7M
Q4 24
$13.1M
$-18.9M
Q3 24
$13.1M
$-21.0M
Q2 24
$14.2M
$-25.6M
Gross Margin
CCBG
CCBG
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
CCBG
CCBG
PRCT
PRCT
Q1 26
-4.1%
Q4 25
29.3%
-40.6%
Q3 25
32.0%
-27.8%
Q2 25
31.7%
-28.0%
Q1 25
35.8%
-39.7%
Q4 24
29.0%
-28.9%
Q3 24
26.1%
-38.4%
Q2 24
29.3%
-50.3%
Net Margin
CCBG
CCBG
PRCT
PRCT
Q1 26
-38.1%
Q4 25
21.6%
-39.1%
Q3 25
24.2%
-25.7%
Q2 25
23.8%
-24.7%
Q1 25
27.4%
-35.8%
Q4 24
21.9%
-27.6%
Q3 24
22.0%
-35.9%
Q2 24
24.0%
-48.0%
EPS (diluted)
CCBG
CCBG
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.80
$-0.54
Q3 25
$0.93
$-0.38
Q2 25
$0.88
$-0.35
Q1 25
$0.99
$-0.45
Q4 24
$0.78
$-0.34
Q3 24
$0.77
$-0.40
Q2 24
$0.83
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCBG
CCBG
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$552.9M
$347.7M
Total Assets
$4.4B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCBG
CCBG
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
CCBG
CCBG
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CCBG
CCBG
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$552.9M
$365.9M
Q3 25
$540.6M
$380.3M
Q2 25
$526.4M
$385.8M
Q1 25
$512.6M
$389.2M
Q4 24
$495.3M
$402.2M
Q3 24
$476.5M
$241.2M
Q2 24
$461.0M
$251.8M
Total Assets
CCBG
CCBG
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$4.4B
$508.1M
Q3 25
$4.3B
$511.5M
Q2 25
$4.4B
$513.1M
Q1 25
$4.5B
$519.4M
Q4 24
$4.3B
$534.0M
Q3 24
$4.2B
$374.1M
Q2 24
$4.2B
$374.4M
Debt / Equity
CCBG
CCBG
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCBG
CCBG
PRCT
PRCT
Operating Cash FlowLast quarter
$87.6M
Free Cash FlowOCF − Capex
$80.0M
FCF MarginFCF / Revenue
126.1%
Capex IntensityCapex / Revenue
12.0%
Cash ConversionOCF / Net Profit
6.39×
TTM Free Cash FlowTrailing 4 quarters
$150.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCBG
CCBG
PRCT
PRCT
Q1 26
Q4 25
$87.6M
$-10.3M
Q3 25
$21.6M
$-6.6M
Q2 25
$32.6M
$-15.0M
Q1 25
$21.9M
$-17.0M
Q4 24
$63.6M
$-32.4M
Q3 24
$12.8M
$-18.8M
Q2 24
$24.9M
$-15.7M
Free Cash Flow
CCBG
CCBG
PRCT
PRCT
Q1 26
Q4 25
$80.0M
$-12.2M
Q3 25
$19.8M
$-9.5M
Q2 25
$30.8M
$-17.8M
Q1 25
$19.5M
$-18.8M
Q4 24
$54.9M
$-33.6M
Q3 24
$10.5M
$-19.0M
Q2 24
$23.0M
$-16.8M
FCF Margin
CCBG
CCBG
PRCT
PRCT
Q1 26
Q4 25
126.1%
-15.9%
Q3 25
30.1%
-11.4%
Q2 25
48.7%
-22.5%
Q1 25
31.7%
-27.2%
Q4 24
91.7%
-49.2%
Q3 24
17.6%
-32.6%
Q2 24
39.0%
-31.4%
Capex Intensity
CCBG
CCBG
PRCT
PRCT
Q1 26
Q4 25
12.0%
2.4%
Q3 25
2.6%
3.4%
Q2 25
2.9%
3.5%
Q1 25
3.9%
2.7%
Q4 24
14.5%
1.7%
Q3 24
3.8%
0.4%
Q2 24
3.3%
2.0%
Cash Conversion
CCBG
CCBG
PRCT
PRCT
Q1 26
Q4 25
6.39×
Q3 25
1.35×
Q2 25
2.17×
Q1 25
1.30×
Q4 24
4.86×
Q3 24
0.97×
Q2 24
1.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCBG
CCBG

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons